You are here

  • Home
  • Archive
  • Volume 1, Issue 1
  • Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study

Article metrics

Article menu
Research
Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study

 

Online download statistics by month:

Online download statistics by month: June 2022 to March 2024

AbstractFullPdf
Jun 2022866849153
Jul 2022915870213
Aug 202214310037
Sep 20221239224
Oct 20221509931
Nov 202215813653
Dec 202220019535
Jan 202312111715
Feb 202312211677
Mar 202315414773
Apr 202311710764
May 2023646034
Jun 20239910038
Jul 2023888731
Aug 2023696723
Sep 202337368
Oct 2023545333
Nov 2023818033
Dec 202312412127
Jan 20244742187
Feb 202414414024
Mar 202411711727
Total399337311240